Market News How it works Learn FAQ
| RCT 0.0923 21.29% | NU 12.5021 -17.53% | EWZ 34.02 -20.12% | BBD 2.877 -29.31% | TGL 0.2429 9.66% | AZTR 2.05 186.71% | ITUB 7.68 -20.58% | SRTM 0.2775 -35.51% | NVD 3.995 -4.65% | XP 15.4801 -49.10% | WFF 0.089 11.25% | SHFS 0.091 -31.27% | SPCX 149.37 1.27% | SOXL 92.37 10.54% | PBR 22.715 -13.17% | VALE 11.99 -3.31% | CLRO 4.84 48.92% | INTC 91.75 5.51% | GCDT 0.1443 -18.06% | TSLL 10.885 11.53% | NWGL 0.0872 6.34% | NOK 8.715 7.06% | NVDA 216.1126 2.44% | SOXS 46.95 -10.50% | CRWV 56.22 3.66% | BITO 10.695 -1.25% | RWM 14.475 -0.52% | GPUS 0.1858 10.01% | SGRY 23.185 47.21% | TSLG 5.445 11.81% | ABEV 2.805 -15.00% | JBLU 2.285 -12.95% | IREN 26.025 4.50% | INTR 4.595 -36.09% | RBNE 0.1682 -11.47% | QID 14.1701 -2.61% | AAL 12.1792 0.57% | TQQQ 68.8286 3.83% | SBS 4.6303 -27.65% | SPDN 8.485 -0.64% | TSLA 393.84 5.81% | T 20.6998 -1.10% | LUCD 0.538 30.90% | SID 0.9075 -23.09% | WULF 12.3201 8.83% | XTND 2.2899 29.37% | NFLX 63.005 -4.32% | CIFR 7.885 -0.69% | SQQQ 38.17 -3.81% | RIG 6.555 2.26%
NRNeurAxis, Inc. logo

NeurAxis, Inc. (NRXS)

New York Stock Exchange Arca · Currency in USD
$7.33 ▼ -0.07 (-0.95%)
As of Oct 26, 2:34 PM ET. Market open.

Summary

Previous Close
$7.40
Open
$7.38
Day's Range
$7.31 – $7.45
52 Week Range
$2.21 – $9.33
Volume
70,941
Avg. Volume
115,354
Market Cap
$92.05M
Beta (5Y Monthly)
1.37
PE Ratio (TTM)
--
EPS (TTM)
-$0.65
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$8.00

Profile: NeurAxis, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
24
CEO
Brian Carrico

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$0.21 · Revenue est. $2.10M
DateEst.Actual
Aug 11, 2026-$0.32-$0.19Beat
May 12, 2026-$0.19-$0.18Beat
Mar 19, 2026-$0.22-$0.17Beat
Nov 10, 2025-$0.20-$0.24Miss
Aug 12, 2025-$0.19-$0.22Miss
May 12, 2025-$0.24-$0.31Miss

Analyst view

Consensus price target
$8.00 ▲ +9.1%
Range $8.00 – $8.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on NRXS and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.